Dendritic cells (DC) are professional antigen-presenting
cells that are specialized in the uptake of antigens and
their transport from peripheral tissues to the lymphoid
organs. Because of their capacity to stimulate naïve T
cells, DC have a central role in the initiation of primary
immune responses and are considered promising tools
and targets for immunotherapy. Investigating the signals
that regulate the function of DC, the sentinels of the immune
system, is also critical to understanding the role of
DC in the regulation of immune response. We have assessed
the effects of natural antibodies in the form of
therapeutic intravenous immunoglobulins (IVIg) on the
regulation of the function of DC. We have observed that
DC are the primary targets for the immunosuppressive
effects of IVIg on T-cell activation. This review focuses on
the effects of IVIg on DC development and function.